Indian pharmaceutical exports increased by 8 per cent in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10 per cent increase by year’s end.

Pharma exports to the European Union and other CIS countries, which were affected by the ongoing war in Ukraine and subsequent limitations, are expected to improve once the situation returns to normal.

India’s pharmaceutical exports totalled $24.61 billion in FY22, an increase of 1 per cent over FY21. According to recent comments from Union Minister Mansukh Mandaviya, exports of Made in India medicinal products increased by 146 per cent from April to June 2022 compared to the same period in 2013.